ESS vs GSK · P/E 31, rev $489.0M vs P/E 13, $103.31B cap
Essex Property Trust Inc (ESS) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Essex Property Trust Inc (ESS) is a reit - residential company listed on NYSE.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported ESS revenue for 2026-06-30 was $489.0M. Net income was $66.9M. Revenue was up 0.9% from 2026-03-31 to 2026-06-30. ESS currently screens at market cap $18.91B and trailing P/E 30.9.
GSK does not have a complete income-statement cache yet.
ESS currently screens at market cap $18.91B and trailing P/E 30.9. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the ESS and GSK stock pages for the full models.
Not investment advice.